Immunopathophysiological aspects of an emerging neonatal infectious disease reduced by a bacterial superantigen

Journal of Clinical Investigation

Volumn 106, Issue 11, 2000, Pages 1409-1415

  Takahashi, Naoto ^a   Kato, Hidehito ^a   Imanishi, KeN'Ichi ^a   Miwa, Keishi ^b   Yamanami, Sadao ^c   Nishida, Hiroshi ^a   Uchiyama, Takehiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

^c Kawaguchi Municipal Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD45 ANTIGEN; IMMUNOTOXIN; SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; HUMAN; IMMUNOPATHOLOGY; LYMPHOCYTE COUNT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEONATAL TOXIC SHOCK SYNDROME LIKE EXANTHEMATOUS DISEASE; NEWBORN; NEWBORN INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0033653538     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10396     Document Type: Article

References (28)

1. A new exanthematous disease in newborn infants
2. A new exanthematous disease with thrombocytopenia in newborn infants
3. Neonatal thrombocyropenia with skin eruption, probably caused by exotoxin-producing methicillin-resistant Staphylococcus aureus (MRSA): Clinical evaluation in 14 cases
4. Clinical studies of early neonatal exanthematous disease with thrombocytopenia: In relation to methicillin resistant Staphylococcus aureus (MRSA)
5. Bacterial examinations of a new exanthematous disease in newborn infants
6. Exanthema of the newborn related to toxic shock syndrome toxin-1 (TSST-1)
7. Superantigens and their potential role in human disease
8. Bacterial superantigens: Mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases
9. Study of the biological activities of toxic shock syndrome toxin-1: Induction of the proliferative response and interleukin 2 production by T cells from human peripheral mononuclear cells stimulated with the toxin
10. Activation of human T cells by toxic shock syndrome toxin-1: The toxin binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules
11. Selective expansion oft cells expressing Vβ2 in toxic shock syndrome
12. Interaction of Staphylococcus aureus toxin 'superantigens' with human T cells
13. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period
14. The epidemiology of MRSA producing TSST-1 and the influence of serum on the production of TSST-1
15. The progressive intercontinental spread of methicillinresistant Staphylococcus aureus
16. Staphylococcus aureus: A well-armed pathogen
17. + T cells in Staphylococcus enterotoxin B-primed mice
18. + T cells by staphylococcal enterotoxin B
19. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen
20. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen
21. + T cells
22. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease
23. Developmental immunology and role of host defenses in neonatal susceptibility
24. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: Implications for toxic shock syndrome
25. 'Actively acquired tolerance' of foreign cells
26. Neonatal tolerance mysteries solved
27. Superantigen vaccines: A comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A